Cargando…

Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches

Neuroblastoma (NB) is the most common extra-cranial solid tumor of childhood and arises from developing sympathetic nervous system. Most primary tumors localize in the abdomen, the adrenal gland, or lumbar sympathetic ganglia. Amplification in tumor cells of MYCN, the major oncogenic driver, patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bottino, Cristina, Dondero, Alessandra, Bellora, Francesca, Moretta, Lorenzo, Locatelli, Franco, Pistoia, Vito, Moretta, Alessandro, Castriconi, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921882/ https://www.ncbi.nlm.nih.gov/pubmed/24575100 http://dx.doi.org/10.3389/fimmu.2014.00056

Ejemplares similares

NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis
por: Vitale, Massimo, et al.
Publicado: (1998)

Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
por: Pistoia, Vito, et al.
Publicado: (2018)

B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma
por: Bottino, Cristina, et al.
Publicado: (2023)

Molecular Mechanisms Directing Migration and Retention of Natural Killer Cells in Human Tissues
por: Castriconi, Roberta, et al.
Publicado: (2018)

Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells
por: Vitale, Chiara, et al.
Publicado: (2023)

Transplantation and innate immunity: the lesson of natural killer cells
por: Bertaina, Alice, et al.
Publicado: (2009)

TGF-β1 Downregulates the Expression of CX(3)CR1 by Inducing miR-27a-5p in Primary Human NK Cells
por: Regis, Stefano, et al.
Publicado: (2017)

Identification of neuroblastoma cell lines with uncommon TAZ(+)/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells
por: Canzonetta, Claudia, et al.
Publicado: (2021)

NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27
por: Dondero, Alessandra, et al.
Publicado: (2017)

Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule
por: Gregorio, A, et al.
Publicado: (2008)

p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
por: Sivori, Simona, et al.
Publicado: (1997)

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
por: Brandetti, Elisa, et al.
Publicado: (2017)

Identification and Molecular Cloning of P75/Airm1, a Novel Member of the Sialoadhesin Family That Functions as an Inhibitory Receptor in Human Natural Killer Cells
por: Falco, Michela, et al.
Publicado: (1999)

Late Development of FcεRγ(neg) Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients
por: Muccio, Letizia, et al.
Publicado: (2018)

NKp44, A Triggering Receptor Involved in Tumor Cell Lysis by Activated Human Natural Killer Cells, Is a Novel Member of the Immunoglobulin Superfamily
por: Cantoni, Claudia, et al.
Publicado: (1999)

Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule
por: Bottino, Cristina, et al.
Publicado: (2003)

Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis
por: Tabellini, Giovanna, et al.
Publicado: (2014)

Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants
por: Bottino, Cristina, et al.
Publicado: (2022)

Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells
por: Pende, Daniela, et al.
Publicado: (1999)

Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1
por: Casu, Beatrice, et al.
Publicado: (2019)

Gntb-A, a Novel Sh2d1a-Associated Surface Molecule Contributing to the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected B Cells in X-Linked Lymphoproliferative Disease
por: Bottino, Cristina, et al.
Publicado: (2001)

Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells
por: Locatelli, Franco, et al.
Publicado: (2013)

NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms
por: Regis, Stefano, et al.
Publicado: (2020)

X-Linked Lymphoproliferative Disease: 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells
por: Parolini, Silvia, et al.
Publicado: (2000)

Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
por: Pende, Daniela, et al.
Publicado: (2019)

Natural Killer Cells in Healthy and Diseased Subjects
por: Biassoni, Roberto, et al.
Publicado: (2011)

Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response
por: Morandi, Barbara, et al.
Publicado: (2012)

Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
por: Marrella, Alessandra, et al.
Publicado: (2019)

Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants
por: Dondero, Alessandra, et al.
Publicado: (2021)

Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural Cytotoxicity
por: Pessino, Anna, et al.
Publicado: (1998)

Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies
por: Vitale, Chiara, et al.
Publicado: (2022)

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
por: Cantoni, Claudia, et al.
Publicado: (2016)

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells
por: Ziegler, Sabrina, et al.
Publicado: (2017)

Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
por: Moretta, Lorenzo, et al.
Publicado: (2014)

NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation
por: Vacca, Paola, et al.
Publicado: (2016)

Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor
por: Pesce, Silvia, et al.
Publicado: (2016)

Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells
por: Carrega, Paolo, et al.
Publicado: (2009)

KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing
por: Carlomagno, Simona, et al.
Publicado: (2017)

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
por: Morandi, Fabio, et al.
Publicado: (2018)

Immunotherapeutic Strategies for Neuroblastoma: Present, Past and Future
por: Morandi, Fabio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t1s90h5odvsu8ieo5vqbd7o5qf